Hi again!
Our May meetup is coming next week! Please make sure to signup.
Talk 1: Ira Ktena - Twitter UK
Title
Deep learning on graphs for neuroimaging
Abstract
Graph representations are often used to model structured data at an individual or population level and have numerous applications in pattern recognition problems. In the field of neuroscience, where such representations are commonly used to model structural or functional connectivity between a set of brain regions, graphs have proven to be of great importance to reveal patterns related to brain development and disease, which were previously unknown. This talk is going to cover the evaluation of similarity between brain connectivity networks in a manner that accounts for the graph structure and is tailored for a particular application.
Bio
Ira is a Research Scientist with the Cortex Applied Machine Learning team at Twitter UK. She recently completed her PhD in Medical Image Computing at Imperial College London under the supervision of Professor Daniel Rueckert, during which she visited the Stroke Group at Massachusetts General Hospital in Boston. Her research focused on developing methods for modelling and analysing graph-structured neuroimaging data at an individual or population level using traditional graph theoretical approaches and geometric deep learning. Last summer she spent some time as a Research Intern with Spotify London working on audio generative models and machine learning for audio understanding.
******************************************************************************
Talk 2: Oxford Cancer Biomarkers (OCB) - computer vision to advance precision medicine
Neil Cornish – Business Development Director, Meridian IT Ltd
David Browning – Chief Executive Officer, Oxford Cancer Biomarkers
Abstract
Internationally renowned Professors David Kerr and Nick La Thangue started OCB from the laboratories of the University of Oxford in 2012. Their aim was to discover and develop biomarkers using screening platforms to advance personalised medicine within oncology, specifically colorectal cancer and its treatments. Since then, they have built a world class development team consisting of industry professionals, leading scientists and oncologists, retaining strong links to Oxford University.
Bios
